Concepedia

Yajing Bao

YB

Statistics

Publications

16

Citations

419

H-Index

13

Active since

2004

Affiliations

Harvard University(Current)

Dalian Minzu University

University of the Witwatersrand

Social and Scientific Systems (United States)

University of California San Diego

Yajing Bao is an author at Harvard University specializing in antiviral therapy, antiretroviral therapy, and antiviral pharmacotherapy.

ORCID

Publications per year

2004–2020

16

Publications

16

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

, , +10

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Anthony T. Podany, Yajing Bao, Susan Swindells et al. · Clinical Infectious Diseases · 2015 · 73 citations · Full text

, , +17

Low-Frequency Nevirapine (NVP)–Resistant HIV-1 Variants Are Not Associated With Failure of Antiretroviral Therapy in Women Without Prior Exposure to Single-Dose NVP

Valerie F. Boltz, Yajing Bao, Shahin Lockman et al. · The Journal of Infectious Diseases · 2014 · 31 citations · Full text

, , +16

Physiological Responses of Alfalfa to High-level Salt Stress: Root Ion Flux and Stomatal Characteristics

Peng Guo, Hongxu Wei, Wanjun Zhang et al. · International Journal of Agriculture and Biology · 2015 · 28 citations · Full text

, , +17

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

Susan A. Fiscus, Susan Cu‐Uvin, Abel Tilahun Eshete et al. · Clinical Infectious Diseases · 2013 · 24 citations · Full text

, , +16

1–5 of 16